Stockreport

How FDA Review of Sarepta's ESSENCE Data At Sarepta Therapeutics (SRPT) Has Changed Its Investment Story [Yahoo! Finance]

Sarepta Therapeutics, Inc.  (SRPT) 
Last sarepta therapeutics, inc. earnings: 2/26 04:05 pm Check Earnings Report
PDF of AMONDYS 45 and VYONDYS 53 from accelerated to traditional approvals, using data from the ESSENCE Phase 3 study and real-world evidence in Duchenne muscular dystrophy. [Read more]